DOAR Releases Results from a National Survey of Jurors’ Attitudes Toward Pharmaceutical Companies
May 14, 2024, New York, NY—DOAR, the nation’s leading trial consulting company, today released important findings from a new national study that examines several issues suspected of influencing jurors’ baseline attitudes toward pharmaceutical companies. The findings indicate that opinions of the pharmaceutical industry are generally favorable despite a prevailing view of it as profit-centric. The study also concludes that recent trends in certain types of drugs and vaccines have a meaningful impact on views of the industry. The study, conducted by the DOAR Research Center, sought to reflect a broad spectrum of community attitudes across the United States. It was